By NPA chief pharmacist Leyla Hannbeck.

If Australia’s experience is anything to go by, we all need to be ready to deal with a particularly bad flu outbreak this year.

NHS chief executive Simon Stevens has warned that the UK could be in for an exceptionally bad flu outbreak this winter. Australia experienced its worst ever outbreak during its winter, and global circulation means there is a risk of the same here.

Read More

Steve Anderson, managing director, Phoenix Healthcare Distribution.

In the hustle and bustle of everyday life in community pharmacy, it is easy to lose sight of storms brewing on the horizon. One of the biggest is the implementation of the Falsified Medicines Directive.

The aim of the directive is to prevent falsified medicines entering the legal supply chain. It is due to be implemented in UK law by February 2019. What started life as a modest initiative focused on a handful of “high risk” medicines is morphing into an expensive, impractical and bureaucratic behemoth.

Read More

By Ross Ferguson, pharmacist and writer.

We need to move with the times and stop suggesting pharmacy faces an either/or future, either technology driven or community based. Why can’t we have both?

I completely disagree with NPA chairman Ian Strachan when he says there are two paths that pharmacy can take: either “mass automation, centralised dispensing and pharmacists working predominantly from GP practices or remotely” or “community pharmacies better integrated with other services, operating efficiently as neighbourhood health and wellbeing centres, and being a front door to the NHS”.

Read More

By Pharmacy Magazine editor, Richard Thomas.

Autumn has descended suddenly but everywhere you look the temperature’s rising.

Doctors have fired off their annual salvo at pharmacists over flu jabs, Alliance Healthcare has been feeling the heat over its deliveries meltdown (since resolved) and everyone is hot under the collar about what the Government’s rebalancing board may – or may not – be considering about supervision.

 

Read More

By Pharmacy Magazine editor, Richard Thomas.

The row over the cost of EHC from pharmacies – and the overwrought tone of much of the ensuing media coverage – raises serious questions about the perceived value of pharmacists’ professional input and how this should best be remunerated.

Clearly, price can be a barrier to medicines access and there is an onus on all pharmacies to ensure that EHC is affordable. But is the cost of EHC, for those who have to pay, unjustifiably high? The British Pregnancy Advisory Service and Faculty of Sexual and Reproductive Healthcare certainly think so. Presumably Superdrug and Tesco now agree with them.

Read More

Previous 1 2 3 4 5 ... 34 Next

Latest

PHE updates guidance on managing common infections

PHE has updated its advice on ’Managing common infections: guidance for primary care’

NHS negligence bill quadruples in a decade

The Government must take steps to rein in the increasing cost of clinical negligence claims as numbers rocket, NAO warns

Views

Flu jabs: let’s do a fantastic job

By NPA chief pharmacist Leyla Hannbeck. If Australia’s experience is anything to go by, we all need to be ready to dea...

Popular

When to give antibiotics for common infections

NICE is giving specific advice about when antibiotics should be prescribed for conditions such as sore throats and colds

Lloyds takes Times to task over EHC coverage

LloydsPharmacy has written to The Times calling for “more clinically appropriate and accurate coverage” about EHC

Pharmacies in London supporting shingles jab

Pharmacies in London are helping to raise awareness of the national NHS shingles vaccination programme